Budesonide inhalation suspension in single-dose ampules had a market value of roughly $385.4 million, according to IQVIA March 2019 data.
|
|
Budesonide inhalation suspension in single-dose ampules had a market value of roughly $385.4 million, according to IQVIA March 2019 data. |
Original Article: Lupin launches generic Pulmicort Respules